Diabetes does not damage the body from one location. It changes cells in nearly every organ, and the cumulative effect of those changes is what drives complications ranging from kidney failure to blindness. The process begins in the insulin-producing beta cells of the pancreas but radiates outward to muscle, fat, liver, blood vessels, kidneys, eyes, and nerves. Understanding how each cell type is altered helps explain why diabetes, left poorly managed, affects so many seemingly unrelated parts of the body.
Where It Starts: Beta Cells Under Siege
The pancreatic beta cell is the body’s sole meaningful source of insulin. In both type 1 and type 2 diabetes, these cells are damaged or lost, though by different routes. In type 2 diabetes, the primary stress comes from chronic exposure to high blood sugar and elevated fatty acids, a combination researchers call glucolipotoxicity. When beta cells are flooded with excess glucose for prolonged periods, they are pushed to synthesize more and more insulin. That overload triggers a stress response in the endoplasmic reticulum, the part of the cell that folds and packages proteins. The cell essentially cannot keep up with the demand, leading to misfolded insulin molecules, incomplete insulin production, and impaired secretion.1PubMed Central. Developmental Programming and Glucolipotoxicity: Insights on Beta Cell Inflammation and Diabetes
The damage does not stop there. Fatty acids compound the problem through several additional pathways, including building up toxic lipid byproducts that interfere with survival signals inside the cell and ramping up oxidative stress.2Diabetes & Metabolism Journal. Glucolipotoxicity in Pancreatic β-Cells Research on insulin-producing cell lines has shown that chronic high glucose directly causes endoplasmic reticulum stress and activates a protein called SREBP-1, which further disrupts the cell’s internal signaling and may represent a shared mechanism linking beta cell failure with insulin resistance elsewhere in the body.3Journal of Cell Science. ER stress and SREBP-1 activation are implicated in β-cell glucolipotoxicity
Importantly, beta cell loss in type 2 diabetes is not purely about cell death. Some beta cells appear to “dedifferentiate,” reverting to a more primitive state where they no longer produce insulin but are not technically dead. This has shifted the scientific conversation from viewing beta cell loss as irreversible toward exploring whether some of those cells could, under the right conditions, be coaxed back into function.4PubMed. Death versus dedifferentiation: The molecular bases of beta cell mass reduction in type 2 diabetes
The Autoimmune Route in Type 1 Diabetes
In type 1 diabetes, the immune system itself destroys beta cells. T cells, a type of white blood cell that normally fights infections, mistakenly identify beta cells as foreign and attack them. Both CD4 and CD8 T cells play roles in this destruction.5PubMed Central. T Cell-Mediated Beta Cell Destruction: Autoimmunity and Alloimmunity in the Context of Type 1 Diabetes The attack is not a solo effort by T cells alone. Research has found that another immune cell type, called plasmablasts, acts as a kind of helper by presenting beta cell fragments to CD4 T cells and fueling their inflammatory response, which accelerates beta cell killing.6PubMed Central. Increased plasmablasts enhance T cell-mediated beta cell destruction and promote the development of type 1 diabetes By the time type 1 diabetes is diagnosed, the majority of beta cells have already been destroyed, which is why lifelong insulin replacement is necessary.
Muscle Cells Stop Responding
Skeletal muscle is responsible for absorbing a large share of the glucose in your blood after a meal, and it does so by moving a transporter protein called GLUT4 to its surface. Insulin is the signal that triggers this movement. In insulin resistance, the signaling chain between insulin arriving at the muscle cell and GLUT4 reaching the surface breaks down. Studies in animals fed high-fat diets show that GLUT4 movement to the cell membrane is almost completely blocked, with early signaling steps inside the cell reduced by roughly 40%.7PubMed. Defective insulin-induced GLUT4 translocation in skeletal muscle of high fat-fed rats is associated with alterations in both Akt/protein kinase B and atypical protein kinase C (zeta/lambda) activities
Fatty acids are a direct culprit here too. When muscle cells are exposed to the fatty acid palmitate, toxic lipid byproducts accumulate inside the cell, and the signaling that normally shuttles GLUT4 to the surface drops by about 40% within just six hours.8PubMed. Two phases of palmitate-induced insulin resistance in skeletal muscle: impaired GLUT4 translocation is followed by a reduced GLUT4 intrinsic activity The practical consequence is straightforward: glucose lingers in the bloodstream instead of entering muscle cells, and blood sugar rises.
Fat Cells Grow, Inflame, and Leak
Fat tissue is not a passive storage site. It is an active endocrine organ, releasing hormones and signaling molecules that influence metabolism body-wide. When fat cells enlarge beyond a healthy size, a state called hypertrophy, their behavior shifts. Enlarged fat cells release less adiponectin, a hormone that normally promotes insulin sensitivity and dampens inflammation, while pumping out more leptin and inflammatory signals like IL-6 and MCP-1.9PubMed Central. Disrupted adipokine secretion and inflammatory responses in human adipocyte hypertrophy Fat cell size alone predicts a range of metabolic problems, including abnormal blood lipids, ectopic fat buildup in organs like the liver, and insulin resistance.10PubMed Central. Fat Cell Size: Measurement Methods, Pathophysiological Origins, and Relationships With Metabolic Dysregulations
The inflammatory shift in fat tissue also attracts immune cells. In lean, healthy people, fat tissue contains macrophages in a relatively calm, anti-inflammatory state. In obesity and type 2 diabetes, the number of macrophages in fat tissue increases, and they switch to a pro-inflammatory profile, releasing cytokines that directly worsen insulin resistance in muscle and liver.11PubMed Central. Metabolic Regulation of Adipose Tissue Macrophage Function in Obesity and Diabetes Inflamed fat tissue also becomes less responsive to insulin’s signal to hold onto its stored fatty acids. The result is increased leakage of fatty acids into the bloodstream, which drives fat accumulation in the liver and fuels glucose production there.12Journal of Clinical Investigation. The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux
The Liver Paradox
Liver cells in diabetes develop a puzzling contradiction. Normally, insulin tells the liver to stop producing glucose and to start making fat for storage. In insulin resistance, the liver ignores the “stop producing glucose” signal but continues obeying the “make fat” signal. The result is simultaneous overproduction of glucose, which raises blood sugar, and overproduction of fat in the form of triglycerides, which raises blood lipid levels and contributes to fatty liver disease.13PubMed Central. Resolving the Paradox of Hepatic Insulin Resistance This selective resistance, obeying one insulin command while ignoring another, is one of the reasons diabetes so often comes packaged with abnormal cholesterol and liver problems.
Blood Vessel Damage and the Role of Sugar-Coated Proteins
High blood sugar takes a particular toll on the cells lining blood vessels. In people with diabetes, atherosclerosis (the buildup of fatty deposits in artery walls) is the leading reason for reduced life expectancy, and damage to tiny blood vessels is the biggest driver of kidney disease and vision loss.14PubMed Central. Vascular complications of diabetes: mechanisms of injury and protective factors
One of the key mechanisms behind this vascular damage involves advanced glycation end products, or AGEs. When blood sugar stays elevated, glucose molecules stick to proteins, fats, and even DNA, forming permanent cross-links that stiffen tissues and alter cell behavior. AGEs also bind to specific receptors on cell surfaces, triggering the release of inflammatory molecules and free radicals that damage the vessel wall from the inside.15PubMed Central. Advanced glycation end products and diabetic complications These sugar-modified proteins accumulate over years, which is one reason long-term blood sugar control matters so much for preventing complications.
The Mitochondrial Thread
Across many of these cell types, a shared vulnerability ties the damage together: mitochondria, the energy-producing structures inside cells. In a chronically high-sugar environment, the mitochondrial machinery that generates energy becomes impaired, leaking reactive oxygen species (free radicals) that damage DNA, proteins, and cell membranes. The buildup of these free radicals triggers a chain reaction that can lead to cell death.16PubMed Central. The impact of oxidative stress-induced mitochondrial dysfunction on diabetic microvascular complications Research in endothelial cells has shown that when mitochondrial free radical production is brought back to normal, many of the classic molecular mechanisms of diabetic complications, including AGE formation and toxic sugar alcohol accumulation, are prevented. This suggests that mitochondrial dysfunction is not just one problem among many; it may be the upstream trigger for several downstream damage pathways in blood vessels, kidneys, beta cells, and the liver.17PubMed. Impact of mitochondrial ROS production in the pathogenesis of diabetes mellitus and its complications
Kidney Cells That Filter Your Blood
Your kidneys filter blood through tiny structures that rely on specialized cells called podocytes, which wrap around blood vessels and form a sieve-like barrier. Podocytes are the major determinant of whether protein leaks into your urine, and their injury is the central event in diabetic kidney disease.18PubMed Central. Podocyte Injury in Diabetic Kidney Disease: A Focus on Mitochondrial Dysfunction Under the stress of diabetes, podocytes undergo structural damage: their delicate foot-like projections flatten and merge, the membrane they sit on thickens, and ultimately they detach and die.19Nature Communications. Podocyte OTUD5 alleviates diabetic kidney disease through deubiquitinating TAK1 and reducing podocyte inflammation and injury Multiple damaging pathways converge on these cells simultaneously, disrupting their internal skeleton, overwhelming their self-repair mechanisms, and eventually depleting them from the kidney altogether.20PubMed. Mechanisms and Current Therapeutic Targets of Podocyte Damage in Diabetic Kidney Disease Because adult kidneys generate very few new podocytes, once enough are lost, the filtration barrier fails and kidney function declines irreversibly.
Eyes and Nerves
The retina at the back of the eye depends on tiny blood vessels stabilized by cells called pericytes. These wrap-around cells keep the vessels from bulging or leaking. In diabetes, pericytes are among the first cells to be lost. Their dropout compromises vessel integrity, leading to microaneurysms, leakage, and the hard protein deposits visible on eye exams in early diabetic retinopathy.21PubMed Central. Targeting pericyte retention in Diabetic Retinopathy: a review If the process progresses, new but fragile vessels grow in disorganized patterns and can bleed into the eye, threatening vision.
Peripheral nerves, particularly those in the feet and hands, face their own metabolic assault. When blood sugar is chronically elevated, excess glucose is shunted through a backup metabolic route called the polyol pathway, which converts glucose into sorbitol. This diverts a key cellular resource away from normal nerve function and generates oxidative stress. Research supports the idea that the sheer volume of metabolic traffic through this pathway, rather than the sorbitol concentration itself, is the primary factor in nerve damage.22PubMed Central. Polyol pathway and diabetic peripheral neuropathy The clinical result is numbness, tingling, and pain that typically begins in the extremities.
When the Immune System Itself Falters
Diabetes also changes the immune cells that are supposed to protect you from infections. Neutrophils, the white blood cells that serve as first responders against bacteria, rely heavily on a molecule called NADPH to generate the reactive bursts that kill pathogens. In type 2 diabetes, excess glucose floods into the same polyol pathway that damages nerves, and this depletes the NADPH supply that neutrophils need. With less NADPH, neutrophils produce fewer antimicrobial bursts and have weaker internal antioxidant defenses. The result is a reduced ability to clear infections, which is one reason people with poorly controlled diabetes are more prone to slow-healing wounds and recurrent infections.23PubMed Central. Neutrophil (dys)function due to altered immuno-metabolic axis in type 2 diabetes: implications in combating infections
Why Damage Lingers After Blood Sugar Improves
One of the most unsettling findings in diabetes research is the concept of metabolic memory. Even after blood sugar is brought under control, the damage from earlier periods of poor control continues to drive complications. This phenomenon has been observed both in clinical trials and in animal studies.24PubMed Central. Epigenetic Mechanisms in Diabetic Vascular Complications and Metabolic Memory: The 2020 Edwin Bierman Award Lecture
The mechanism appears to be epigenetic: high glucose leaves chemical marks on DNA and the proteins that package it, changing which genes are switched on or off. These marks persist even after glucose levels return to normal, keeping pro-inflammatory and pro-oxidant programs running in cells that have already been returned to a healthier metabolic environment.25Signal Transduction and Targeted Therapy. Metabolic memory: mechanisms and diseases In practical terms, this means early and sustained blood sugar management carries benefits that extend far beyond the immediate metabolic snapshot. Cells that have never been exposed to prolonged high glucose do not carry these epigenetic scars.26PubMed Central. Update: the role of epigenetics in the metabolic memory of diabetic complications
How Exercise Bypasses the Broken Signal
An encouraging piece of the story involves a workaround that muscle cells have for glucose uptake. Insulin is not the only signal that can move GLUT4 transporters to the cell surface. Physical activity activates an energy-sensing enzyme called AMPK, which triggers GLUT4 translocation independently of insulin. This means that exercising muscle can pull glucose out of the blood even when the insulin signaling pathway is impaired. Activation of AMPK also promotes fat burning, mitochondrial repair, and improved insulin sensitivity over time.27PubMed Central. AMPK and Exercise: Glucose Uptake and Insulin Sensitivity This is one of the clearest biological explanations for why exercise is recommended so strongly in type 2 diabetes management: it exploits a cellular pathway that diabetes has not broken.
Gut Hormone Cells and Bone Marrow
The cellular changes in diabetes extend to less obvious tissues. In the intestine, specialized L-cells produce a hormone called GLP-1 that enhances insulin release after meals and slows stomach emptying. In people with type 2 diabetes, both circulating GLP-1 levels and the number of L-cells producing it are reduced, which weakens the body’s ability to manage post-meal blood sugar spikes.28Gut. Glucagon receptor antagonist upregulates circulating GLP-1 level by promoting intestinal L-cell proliferation and GLP-1 production in type 2 diabetes This is the biological rationale behind the GLP-1 receptor agonist drugs that have become central to modern diabetes treatment: they replace a signal the body has lost.
Even bone marrow is affected. In mouse models of both type 1 and type 2 diabetes, the stem cells that replenish blood and immune cells become trapped in the marrow, unable to mobilize normally. The nerve fibers that regulate stem cell release from bone marrow are damaged by diabetes, and the chemical anchors that hold stem cells in place fail to loosen on cue.29PubMed Central. Diabetes impairs hematopoietic stem cell mobilization by altering niche function This impaired stem cell traffic may help explain why people with diabetes heal more slowly and have reduced regenerative capacity across multiple tissues. It also complicates medical procedures that rely on collecting stem cells from the blood, though this remains an active area of investigation rather than a settled clinical concern.